Overview

Evaluating the Efficacy and Safety of Extended Release Hydromorphone (Exalgo) in Patients With Neuropathic Pain

Status:
Completed
Trial end date:
2011-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out if Exalgo (r) is beneficial for the patients with neuropathic pain.
Phase:
Phase 4
Details
Lead Sponsor:
International Clinical Research Institute
Treatments:
Hydromorphone